BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President & CEO, will present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference.
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President & CEO, will present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference.
